Universität zu Köln

Journal Article

Bishop, Michael R., Dickinson, Michael, Purtill, Duncan, Barba, Pere, Santoro, Armando, Hamad, Nada, Kato, Koji, Sureda, Anna, Greil, Richard, Thieblemont, Catherine, Morschhauser, Franck, Janz, Martin, Flinn, Ian W., Rabitsch, Werner, Kwong, Yok Lam, Kersten, Marie Jose, Minnema, Monique C., Holte, Harald, Chan, Esther Hian Li, Martinez-Lopez, Joaquin, Mueller, Antonia M. S., Maziarz, Richard T., McGuirk, Joseph P., Bachy, Emmanuel, Le Gouill, Steven, Dreyling, Martin, Harigae, Hideo, Bond, David A., Andreadis, Charalambos, McSweeney, Peter A., Kharfan-Dabaja, Mohamed A., Newsome, Simon, Degtyarev, Evgeny, Del Corral, Chris, Andreola, Giovanna, Masood, Aisha, Schuster, Stephen J., Jaeger, Ulrich, Borchmann, Peter and Westin, Jason R. (2021). Tisagenlecleucel Vs Standard of Care As Second-Line Therapy of Primary Refractory or Relapsed Aggressive B-Cell Non-Hodgkin Lymphoma: Analysis of the Phase III Belinda Study. Blood, 138. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Cartron, Guillaume ORCID: 0000-0003-0659-9635, de Guibert, Sophie, Dilhuydy, Marie-Sarah, Morschhauser, Franck, Leblond, Veronique, Dupuis, Jehan, Mahe, Beatrice, Bouabdallah, Reda, Lei, Guiyuan, Wenger, Michael, Wassner-Fritsch, Elisabeth and Hallek, Michael (2014). Obinutuzumab (GA101) in relapsed/refractory chronic lymphocytic leukemia: final data from the phase 1/2 GAUGUIN study. Blood, 124 (14). S. 2196 - 2203. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Freeman, Ciara L., Morschhauser, Franck, Sehn, Laurie, Dixon, Mark, Houghton, Richard, Lamy, Thierry, Fingerle-Rowson, Guenter, Wassner-Fritsch, Elisabeth, Gribben, John G., Hallek, Michael, Salles, Gilles and Cartron, Guillaume ORCID: 0000-0003-0659-9635 (2015). Cytokine release in patients with CLL treated with obinutuzumab and possible relationship with infusion-related reactions. Blood, 126 (24). S. 2646 - 2650. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Freeman, Ciara Louise, Morschhauser, Franck, Sehn, Laurie H., Dixon, Mark, Houghton, Richard, Lamy, Thierry, Fingerle-Rowson, Gunter, Wassner-Fritsch, Elisabeth, Hallek, Michael, Salles, Gilles and Cartron, Guillaume (2014). Pattern of Cytokine Release in Patients with Chronic Lymphocytic Leukemia Treated with Obinutuzumab and Possible Relationship with Development of Infusion Related Reactions (IRR). Blood, 124 (21). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Karuturi, Meghan S., Arai, Sally, Chen, Robert W., Gopal, Ajay K., Feng, Lei, Yuan, Ying, Smith, Scott E., Ansell, Stephen M., Rosenblatt, Joseph D., Savage, Kerry J., Ramchandren, Radhakrishnan, Bartlet, Nancy L., Cheson, Bruce D., Forero-Torres, Andres, Moskowitz, Craig H., Connors, Joseph M., Fanale, Michelle A., de Vos, Sven, Engert, Andreas, Illidge, Tim, Borchmann, Peter, Morschhauser, Franck, Horning, Sandra J. and Younes, Anas (2012). Overall Survival Benefit for Patients with Relapsed Hodgkin Lymphoma Treated with Brentuximab Vedotin After Autologous Stem Cell Transplant. Blood, 120 (21). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 0006-4971

Salles, Gilles A., Boyd, Thomas E., Morschhauser, Franck, Wendtner, Clemens-Martin, Hallek, Michael, Eichhorst, Barbara F., Kozloff, Mark, Cartron, Guillaume, Li, Yan, Hilger, James, Mobasher, Mehrdad and Stilgenbauer, Stephan (2015). Updated Safety and Preliminary Efficacy Data from a Phase 1b Study Combining Venetoclax (GDC-0199, ABT-199) with Bendamustine/Rituximab in Patients with Relapsed/Refractory or Previously Untreated Chronic Lymphocytic Leukemia. Blood, 126 (23). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Stilgenbauer, Stephan, Morschhauser, Franck, Wendtner, Clemens-Martin, Cartron, Guillaume, Hallek, Michael, Eichhorst, Barbara, Kozloff, Mark F., Giever, Thomas, Lozanski, Gerard, Jiang, Yanwen, Huang, Huang, Pignataro, Daniela Soriano, Schary, William, Humphrey, Kathryn, Mobasher, Mehrdad and Salles, Gilles (2018). Safety and Efficacy of Venetoclax (VEN) in Combination with Bendamustine (B) Plus Rituximab (R) or Obinutuzumab (G) in Patients (pts) with Previously Untreated Chronic Lymphocytic Leukemia (CLL): Results from a Phase Ib Study (GO28440). Blood, 132. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Stilgenbauer, Stephan, Morschhauser, Franck, Wendtner, Clemens-Martin, Cartron, Guillaume, Hallek, Michael, Eichhorst, Barbara, Kozloff, Mark F., Giever, Thomas, Lozanski, Gerard, Jiang, Yanwen, Huang, Huang, Pignataro, Daniela Soriano, Schary, William, Humphrey, Kathryn, Mobasher, Mehrdad and Salles, Gilles (2021). Venetoclax plus bendamustine-rituximab or bendamustine-obinutuzumab in chronic lymphocytic leukemia: final results of a phase Ib study (GO28440). Haematologica, 106 (11). S. 2834 - 2845. PAVIA: FERRATA STORTI FOUNDATION. ISSN 0390-6078

Stilgenbauer, Stephan, Morschhauser, Franck, Wendtner, Clemens-Martin, Cartron, Guillaume, Hallek, Michael, Eichhorst, Barbara F., Kozloff, Mark, Giever, Thomas A., Lozanski, Gerard, Punnoose, Elizabeth A., Wang, Jue, Hilger, James, Mobasher, Mehrdad and Salles, Gilles (2016). Phase Ib Study (GO28440) of Venetoclax with Bendamustine/Rituximab or Bendamustine/Obinutuzumab in Patients with Relapsed/ Refractory or Previously Untreated Chronic Lymphocytic Leukemia. Blood, 128 (22). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

von Tresckow, Bastian, Fanale, Michelle, Ardeshna, Kirit M., Chen, Robert, Meissner, Julia, Morschhauser, Franck, Moskowitz, Craig, Zinzani, Pier Luigi, Giezek, Hilde, Balakumaran, Arun, Vo, Thao T., Raut, Monika and Brice, Pauline (2019). Patient-reported outcomes in KEYNOTE-087, a phase 2 study of pembrolizumab in patients with classical Hodgkin lymphoma. Leuk. Lymphoma, 60 (11). S. 2705 - 2712. ABINGDON: TAYLOR & FRANCIS LTD. ISSN 1029-2403

von Tresckow, Bastian, Morschhauser, Franck, Szer, Jeffrey, Eichenauer, Dennis A., Abramson, Jeremy S., Sureda, Anna and Engert, Andreas (2017). Panobinostat consolidation in patients with Hodgkin lymphoma at risk for relapse after high dose chemotherapy and autologous stem cell transplant: final results after early trial discontinuation. Leuk. Lymphoma, 58 (1). S. 222 - 226. ABINGDON: TAYLOR & FRANCIS LTD. ISSN 1029-2403